Search filters

List of works by Amanda L Olson

Allogeneic Transplantation after Myeloablative Rituximab/BEAM ± Bortezomib for Patients with Relapsed/Refractory Lymphoid Malignancies: 5-Year Follow-Up Results

scientific article published on 01 March 2019

Bendamustine added to allogeneic conditioning improves long-term outcomes in patients with CLL.

scientific article

Better allele-level matching improves transplant-related mortality after double cord blood transplantation.

scientific article

Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results

scientific article published on 2 November 2016

Concise review: umbilical cord blood transplantation: past, present, and future

scientific article

Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia

scientific article published on 30 June 2020

Development and validation of a risk assessment tool for BKPyV Replication in Allogeneic Stem cell Transplant Recipients

scientific article published on 30 June 2020

Donor NKG2C Copy Number: An Independent Predictor for CMV Reactivation After Double Cord Blood Transplantation

Double umbilical cord blood transplant is effective therapy for relapsed or refractory Hodgkin lymphoma.

scientific article published on 23 December 2015

Effect of non-permissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T cell depletion

scientific article published on 31 January 2018

Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation

scientific article published on 16 March 2015

Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

scientific article published on 12 May 2017

Fludarabine with a higher versus lower dose of myeloablative timed-sequential busulfan in older patients and patients with comorbidities: an open-label, non-stratified, randomised phase 2 trial

scientific article published on 01 November 2018

General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation

scientific article published on 20 February 2015

Haploidentical Transplants for Patients with Graft Failure After the First Allograft

scientific article published on 29 June 2020

Haploidentical transplantation for acute myeloid leukemia patients with minimal/measurable residual disease at transplantation

scientific article published on 21 October 2019

IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation

scientific article published on 20 July 2016

Impact of Donor Type and Melphalan Dose on Allogeneic Transplantation Outcomes for Patients with Lymphoma

scientific article published on 11 February 2019

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

scientific article published on 01 February 2020

Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation

scientific article published on 11 July 2019

Myeloablative conditioning using timed-sequential busulfan plus fludarabine in older patients with acute myeloid leukemia: long-term results of a prospective phase II clinical trial

scientific article published on 04 April 2019

Pentostatin therapy for steroid-refractory acute graft versus host disease: identifying those who may benefit.

scientific article published on 21 December 2017

Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients

scientific article

Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.

scientific article published on 31 May 2016

Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution

article by Joshua N Kellner et al published 2 November 2018 in Oncotarget

Paulina is supported by:

About Paulina

Help